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Abstract
Background: Spotted 70-mer oligonucleotide arrays offer potentially greater specificity and an
alternative to expensive cDNA library maintenance and amplification. Since microarray fabrication
is a considerable source of data variance, we previously directly tagged cDNA probes with a third
fluorophore for prehybridization quality control. Fluorescently modifying oligonucleotide sets is
cost prohibitive, therefore, a co-spotted Staphylococcus aureus-specific fluorescein-labeled
"tracking" oligonucleotide is described to monitor fabrication variables of a Mycobacterium
tuberculosis oligonucleotide microarray.
Results: Significantly (p < 0.01) improved DNA retention was achieved printing in 15% DMSO/1.5
M betaine compared to the vendor recommended buffers. Introduction of tracking oligonucleotide
did not effect hybridization efficiency or introduce ratio measurement bias in hybridizations
between M. tuberculosis H37Rv and M. tuberculosis mprA. Linearity between the mean log Cy3/Cy5
ratios of genes differentially expressed from arrays either possessing or lacking the tracking
oligonucleotide was observed (R2 = 0.90, p < 0.05) and there were no significant differences in
Pearson's correlation coefficients of ratio data between replicates possessing (0.72 ± 0.07),
replicates lacking (0.74 ± 0.10), or replicates with and without (0.70 ± 0.04) the tracking
oligonucleotide. ANOVA analysis confirmed the tracking oligonucleotide introduced no bias.
Titrating target-specific oligonucleotide (40 µM to 0.78 µM) in the presence of 0.5 µM tracking
oligonucleotide, revealed a fluorescein fluorescence inversely related to target-specific
oligonucleotide molarity, making tracking oligonucleotide signal useful for quality control
measurements and differentiating false negatives (synthesis failures and mechanical misses) from
true negatives (no gene expression).
Conclusions:  This novel approach enables prehybridization array visualization for spotted
oligonucleotide arrays and sets the stage for more sophisticated slide qualification and data filtering
applications.
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Background
Historically, the investigation of genetic alterations has
focused on the study of single genes. In recent years, devel-
opment of DNA microarrays has allowed researchers to
study the complete genome of an organism and profile
transcriptional expression patterns of up to tens of thou-
sands of genes in a single experiment [1-3]. Consequently,
this technology is already providing important insights
into the biological properties of various organisms, mak-
ing it a mainstream component of biomedical research [3-
10].
DNA microarrays are currently based on one of two gen-
eral fabrication formats: (i) light-directed in vitro synthe-
sized oligonucleotide arrays (Affymetrix) [11,12], or (ii)
spotted cDNA or oligonucleotide arrays [3]. While both
platforms allow researchers to compare gene expression
profiles, each format offers unique advantages and disad-
vantages.  In situ synthesized oligonucleotide arrays
offered by Affymetrix are part of a turn-key system that
includes both the DNA microarray platform and the cor-
responding bioinformatic tools. Consequently, investiga-
tors can rapidly begin gene expression studies using "off
the shelf" reagents and optimized protocols. However, the
system and reagents are expensive, thereby limiting the
extent of necessary technical and biological replication
[13]. In addition, Affymetrix-based arrays cannot be fabri-
cated in the academic laboratory, and offer less flexibility
in their design and content compared with spotted cDNA-
or oligonucleotide-based arrays. In contrast, spotted
cDNA- or oligonucleotide-based arrays utilize high-speed
robotics to mechanically or piezoelectrically [14] deposit
small volumes of desired DNA probes onto solid support
surfaces. Although substantial optimization of the fabrica-
tion process by the user laboratory is required, mechani-
cally spotted arrays can be fabricated "in house", are
highly flexible in their design and content, and can be
manufactured in reasonably large numbers providing a
marked cost savings over commercial array platforms.
Spotted oligonucleotide arrays exhibit a number of advan-
tages over cDNA arrays. For example, oligonucleotides
can be synthesized such that homologous sequences
between genes can be excluded, thereby enhancing specif-
icity. In addition, a given gene can be represented by a set
of different oligonucleotides targeting different regions or
exons, allowing for the detection of splice variants, or dis-
crimination of closely related genes, strains, or species.
Finally, oligonucleotides can be purchased "ready-to-
print", by-passing the labor-intensive probe preparation
steps required for utilization of cDNA-based microarrays.
A substantial limitation in the utilization of spotted
cDNA- or oligonucleotide-based arrays are their suscepti-
bility to quality control issues, resulting primarily from
variable DNA probe deposition and retention on the solid
support surfaces. To minimize variations using this fabri-
cation platform, a number of approaches have been
described that allow direct visualization of array integrity
following printing and blocking procedures. Commonly
used methods include the staining of microarrays with
DNA-binding fluorescent dyes, or the hybridization of
"universal" targets (i.e. random 9-mers) to the spotted
DNA elements [15,16]. While these techniques provide
useful information regarding the physical characteristics
of the array, its integrity may be compromised during sub-
sequent de-staining or stripping procedures required prior
to hybridization of labeled targets [16]. Consequently,
investigators typically only examine one or a few repre-
sentative slides to access the quality of a printed batch.
Previously, we have reported the development and use of
a novel three-color cDNA array platform that allows
immobilized probes to be directly visualized [17-19]. Uti-
lizing this format, oligonucleotide primers used to
amplify cDNA targets are labeled at their 5' end with fluo-
rescein, a dye compatible with commonly used cyanine
labeling dyes and confocal laser scanners possessing nar-
row bandwidths [18,20]. Element/array morphology, sur-
face DNA deposition/retention, and surface background
can be monitored on each slide. Thus, in our laboratory,
all cDNA arrays are imaged for quality control prior to
hybridization, maximizing the use of quality arrays for
subsequent experimental procedures. It is likely that many
or all of the benefits to using a directly-coupled fluoro-
phore are also applicable to oligonucleotide-based micro-
arrays; however, synthesis costs make this approach
unfeasible. In this report, we describe the use and evalua-
tion of a Staphylococcus aureus-specific fluorescein-labeled
70-mer "tracking" oligonucleotide as a third-color quality
control measure of a Mycobacterium tuberculosis-specific
oligonucleotide-based microarray.
Results and Discussion
Rationale and design for tracking oligonucleotide
Utilization of oligonucleotide-based DNA microarrays is
limited by the inability to monitor quality control for
every array prior to hybridization. If costs were no consid-
eration, it would be ideal to label each oligonucleotide in
a given microarray set with a third fluorescent dye so that
array fabrication variables could be directly monitored,
analogous to the direct labeling methodology we have uti-
lized with cDNA-based microarrays [18,19]. However,
since this practice is currently cost-prohibitive, we rea-
soned that introduction of a third-color "tracking" oligo-
nucleotide into the printing buffer at low molarity would
allow printing fidelity of a target-specific oligonucleotide
set to be indirectly monitored. A M. tuberculosis oligonu-
cleotide probe set consisting of 4,269 70-mer oligonucle-
otides (Operon) was chosen for these studies as ourBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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laboratory is currently conducting expression profiling
studies on M. tuberculosis strains (Singh and Zahrt, unpub-
lished data).
Probe retention studies
Given the cost of probe material and dependence of data
quality/reproducibility on the amount of support-bound
probe available for hybridization [16,19], maximizing
DNA retention is a critical first step for laboratories fabri-
cating either cDNA- or oligonucleotide-based microar-
rays. An advantage to directly labeling the material being
spotted is the ability to easily monitor probe deposition
efficiency, as there is a direct correlation between the
amount of DNA probe immobilized on the slide surface
and the corresponding fluorescence intensity [18,19].
Here, the utility of a fluoresceinated "tracking" oligonu-
cleotide was investigated to indirectly monitor probe dep-
osition efficiency of a target-specific oligonucleotide set.
To first determine the optimal printing buffer for the 70-
mer oligonucleotide probe set on poly-L-lysine coated
glass slides, a series of 2-fold dilutions of a 5'-fluorescein-
labeled S. aureus-specific tracking oligonucleotide ranging
from 5 µM to 0.078 µM were prepared in two commonly
used printing buffers 50% DMSO and 3X SSC, as well as
15% DMSO/1.5 M betaine. Arrays (n = 25) were evaluated
for DNA retention and spot morphology (size/shape) by
measuring fluorescein fluorescence after post-processing
procedures. Oligonucleotides printed between 0.625 µM
and 0.156 µM were used for direct comparison in these
experiments, as fluorescence from these dilutions were
unsaturated in all three printing buffers [Figure 1; panel A,
rows d-f]. As previously observed with cDNAs [18], signif-
icantly higher retention of the 70-mer tracking oligonucle-
otide was achieved utilizing the 15% DMSO/1.5 M
betaine (5158 +/- 2686 RFU/element; p < 0.01) [Figure 1A
and 1B] compared to the vendor recommended 50%
DMSO (4100 +/- 2792 RFU/element) or 3X SSC (3578 +/
- 2241 RFU/element) print buffers. The standard devia-
tions are large since averages are derived from three differ-
ent concentrations of the dilution series. Because
microarray image analysis is dependent on the spot size
and spot shape, array element morphology obtained with
the various print buffers was also evaluated. Probes
printed in 15% DMSO/1.5 M betaine print buffer consist-
ently produced round spots of the desired size (150.6 +/-
19.6 total pixels; ~120 microns in diameter) [Figure 1A].
In contrast, probes deposited with 50% DMSO produced
larger spots (188.9 +/- 23.1 total pixels) [Figure 1A],
which frequently resulted in merging of adjacent array ele-
ments (data not shown). Probes deposited with 3X SSC
produced the smallest spots of the three buffers evaluated
(120.8 +/- 17.8 total pixels) and exhibited more variable
spot morphology [Figure 1A].
Observation of competitive binding between the tracking 
and target-specific 70-mers
In determining a printing buffer that provided high probe
retention and good spot morphology, we observed that
spotting 0.5 µM tracking oligonucleotide resulted in ele-
ments that were easy to visualize using our standard imag-
ing protocol [Figure 1A]. Therefore we used this
concentration to co-deposit tracking oligonucleotide with
Evaluation of spotting buffers for 70-mer oligonucleotides Figure 1
Evaluation of spotting buffers for 70-mer oligonucleotides. A: 
Serial dilutions of 5'-fluorescein labeled S. aureus tracking oli-
gonucleotide were printed in 15% DMSO/1.5 M betaine (I), 
50% DMSO (II), or 3X SSC (III) print buffers at the indicated 
concentrations and spotted onto poly L-lysine coated glass 
slides. Slides were processed, blocked, and scanned for fluo-
rescein fluorescence. B: Percent retention of 5'-fluorescein-
labeled tracking oligonucleotide on poly L-lysine coated glass 
slides were determined for each print buffer using 25 repli-
cate arrays. Retention of oligonucleotide in each print buffer 
was calculated by determining relative fluorescence units 
(RFU's) at 0.625 µM (row d), 0.313 µM (row e), and 0.156 
µM (row f) from replicate arrays. Values are expressed as 
percent RFU (+/- standard deviation) after normalization to 
the 3X SSC print buffer. Highest retention was obtained with 
the 15% DMSO/1.5 M betaine print buffer.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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Determination of optimal M. tuberculosis target-specific oligonucleotide concentration Figure 2
Determination of optimal M. tuberculosis target-specific oligonucleotide concentration. A: Serial dilutions of 5'-Cy5-labeled 70-
mer oligonucleotides to M. tuberculosis sodA (column 1) or aceA (column 2) were generated in 15% DMSO/1.5 M betaine in the 
presence or absence of 0.5 µM 5'-fluorescein-labeled tracking oligonucleotide and spotted onto poly L-lysine coated glass 
slides. Slides were processed, blocked, and scanned for fluorescein fluorescence (panel I) or Cy5 fluorescence (panel II). A sub-
set of arrays was also hybridized with Cy3-labeled sodA- and aceA-specific PCR products and scanned for Cy3 fluorescence 
(panel III). No loss of hybridization signal is observed following addition of tracking oligonucleotide. B: Fluorescein (red) or Cy5 
(black) mean relative fluorescence intensities from printed oligonucleotide were plotted as a function of Cy5-labeled target-
specific oligonucleotide concentration. Note that the fluorescein intensity derived from the tracking oligonucleotide (red line) 
is informative over approximately two orders of magnitude of M. tuberculosis-specific 70-mer concentration. Bars represent 
S.D. Data were generated from 100 dilution series over 25 arrays.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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40 µM M. tuberculosis target-specific oligonucleotides. To
ensure that a 0.5 uM tracking oligonucleotide concentra-
tion would not interfere with detection of hybridization,
even if the target specific oligonucleotide was at a concen-
tration less than 40 µM, a set of arrays were printed in
which the concentration of two 5'-Cy5-labeled M. tubercu-
losis target-specific 70-mers (aceA and sodA) were serially
diluted from 40 µM to 0.078 µM while maintaining the
tracking oligonucleotide concentration at 0.5 µM. When
visualizing these mixed dilutions immediately after print-
ing, we observed equal fluorescein spot intensity among
all spots in the dilution series, which is consistent with the
manufacturers specifications that the TeleChem SMP3
printing pin deposits approximately 6 nl of probe volume
per contact with the glass surface (image not shown).
However after post-processing, the fluorescein signal
intensity derived from the tracking oligonucleotide was
observed to be inversely related to the intensity of the Cy5
signal derived from the labeled target-specific oligonucle-
otide (Figure 2A, panels I and II), indicating that as molar-
ity of the Cy-5 labeled target-specific oligonucleotide
decreased from the recommended 40 µM (Figure 2A,
panel II, rows a-j), the tracking oligonucleotide was able
to more effectively compete for open sites on the glass sur-
face, resulting in increased fluorescein fluorescence (Fig-
ure 2A, panel I, rows a-j). The observation of this
relationship for 100 dilution series printed over 25 arrays
is plotted in Figure 2B, where the fluorescein intensity
derived from the tracking oligonucleotide (red line) is
shown to be informative over approximately two orders
of magnitude of M. tuberculosis-specific 70-mer concentra-
tion. Cy3-labeled PCR targets complementary to the
immobilized Cy5-labeled aceA and sodA probes were
hybridized to these arrays and no significant difference in
Cy3 hybridization signal intensity between elements pos-
sessing no tracking oligonucleotide versus those possess-
ing 0.5 µM tracking oligonucleotide at each of the 40 µM,
20  µM, or 10 µM target-specific oligonucleotide levels
were detected [Figure 2A, panel III, compare rows a, b and
c to k and l]. Thus, utilization of the 5'-fluorescein-labeled
S. aureus-specific tracking oligonucleotide at 0.5 µM does
not affect hybridization characteristics of M. tuberculosis-
specific target oligonucleotides printed at the manufactur-
ers recommended concentrations of 40 µM or 20 µM.
Introduction of tracking oligonucleotide does not impact 
Cy3/Cy5 ratio measurement
To demonstrate equivalency between data obtained from
individual arrays possessing the tracking oligonucleotide
and arrays lacking the tracking oligonucleotide, experi-
ments were performed on replicate M. tuberculosis array
sets in which tracking oligonucleotide was either excluded
or included in the print buffer. A total of 100 arrays each
containing 5376 total spots (4269 M. tuberculosis probe
set plus 1107 additional positive and negative controls)
were initially printed at 40 µM in 15% DMSO/1.5 M
betaine print buffer lacking tracking oligonucleotide.
Immediately after printing, the oligonucleotide set was
dried down, reconstituted with print buffer possessing 0.5
µM fluoresceinated tracking oligonucleotide, and
reprinted on an additional 100 poly-L-lysine coated glass
slides at a final concentration of 40 µM. A pre-hybridiza-
tion fluorescein image of one sub array from a represent-
ative slide containing the tracking oligonucleotide is
shown (Figure 3A; panel I). As can be observed, incorpo-
ration of tracking oligonucleotide into the print buffer
allowed spotted probes to be efficiently visualized and
utilized for quality control purposes. Array elements con-
taining negative controls consisting of fluoresceinated
tracking oligonucleotide alone (Figure 3A; panel I, black
arrowheads) were visibly more fluorescent than those ele-
ments containing both tracking oligonucleotide and M.
tuberculosis  target-specific oligonucleotides (Figure 3A;
panel I, remaining rows).
We investigated the impact of the tracking oligonucle-
otide on Cy3/Cy5 ratio measurements (n = 12 direct rep-
licates, 6 arrays with and 6 arrays without the tracking
oligonucleotide) using heterotypic hybridizations
between wild-type M. tuberculosis H37Rv and the mprA
mutant strain. The generation of sufficient labeled target
for this experiment required multiple labeling reactions,
and pooling all the labeled targets prior to distribution
over the arrays normalized potential variation between
these reactions. Visual examination of Figure 3A panels I
and II indicate that the image data derived from arrays
printed with or without the tracking oligonucleotide are
equivalent and no cross-hybridization of target to the
tracking oligonucleotide is observed. The resulting
hybridized image data was analyzed with the Matarray
software, which employs a unique quality control algo-
rithm that defines a quality score (qcom) for each spot
[20,21]. Because it was our objective to investigate data
variability inherent to the slide itself versus variability
introduced through hybridization, we filtered, on average
15% of spots on each array that possessed low hybridized
qcom. These spots possessed low scores mainly due to
intensity levels lower than background. After filtering
these spots (many of which were negative controls), 4852
spots common to all arrays were used to determine ratio
correlation values. Linearity between the mean log Cy3/
Cy5 ratio from replicate arrays possessing the tracking oli-
gonucleotide (n = 6) versus those lacking the tracking oli-
gonucleotide (n = 6) was observed (Figure 3B; R2 = 0.67,
p < 0.001). When the analysis was restricted to only those
genes differentially expressed, the coefficient of determi-
nation became more significant, reaching R2 = 0.90. Fur-
thermore, no significant difference in Pearson's
correlation coefficients of mean log Cy3/Cy5 ratio
between replicates possessing the trackingBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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oligonucleotide (0.72 ± 0.07), between replicates lacking
the tracking oligonucleotide (0.74 ± 0.10), and between
replicates with and without the tracking oligonucleotide
(0.70 ± 0.04) were observed. Finally, we identified a total
of 131 genes that were significantly regulated between
wild-type M. tuberculosis H37Rv and the isogenic mprA
mutant at p = 0.05 and performed ANOVA to determine
if individual genes, arrays, or inclusion of the tracking oli-
gonucleotide have a significant effect on the gene expres-
sion measurements [22,23]. The results [Table 1] indicate
that no significant impact on the ratio measurement is
introduced by the tracking oligonucleotide since no sig-
nificant difference is observed between hybridizations
including or excluding the tracking oligonucleotide
(Table 1; row C-, p = 0.2091). Therefore, introduction of
the third-color tracking oligonucleotide into the M. tuber-
culosis oligonucleotide set does not affect hybridization
efficiency or introduce ratio measurement bias through
cross-hybridization, fluorescein signal contamination of
the cyanine dye channels, or quenching interaction with
the cyanine dyes.
Comparison of M. tuberculosis 70-mer oligonucleotide array set printed in the presence or absence of 5'-fluorescein-labeled  tracking oligonucleotide Figure 3
Comparison of M. tuberculosis 70-mer oligonucleotide array set printed in the presence or absence of 5'-fluorescein-labeled 
tracking oligonucleotide. A: Single sub array images of the M. tuberculosis 70-mer oligonucleotide array set printed in the pres-
ence (panels I, fluorescein; and II, Cy3/Cy5) or absence (panel III, Cy3/Cy5) of 5'-fluorescein-labled tracking oligonucleotide. 
Black arrowheads, denote rows containing tracking oligonucleotide only, note high fluorescein intensity (Panel I) and lack of 
cross-hybridization with labeled target (Panel 2). Images shown in panel I and panel II are the same array before and after 
hybridization. B: Scatter plot of mean Cy3/Cy5 log intensity ratios of fluorescence from hybridized arrays printed in the 
absence (x-axis) or presence (y-axis) of 5'-fluorescein-labeled tracking oligonucleotide.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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Table 1: Analysis of Variance (ANOVA) introduced through the addition of tracking oligonucleotide [22].
Row Variance Source Sum2 Degrees of Freedom Mean2 FP r o b  >  F
A Gene 89.745 130 0.69035 1.58 0.0002
B Slide 5.189 5 1.03781 3.38 0.0372
C Tracking Oligo 0.689 1 0.6886 1.58 0.2091
D Gene*Slide 282.851 650 0.43516 1 0.5053
E Gene*Tracking Oligo 57.254 130 0.44041 1.01 0.4558
F Slide*Tracking Oligo 8.275 5 1.65504 3.8 0.0021
G Error 283.146 650 0.43561
H Total 727.148 1571
Use of third-color tracking oligonucleotide for quality control and data filtering Figure 4
Use of third-color tracking oligonucleotide for quality control and data filtering. Pre-hybridization fluorescein image (A) and 
post-hybridization Cy3/Cy5 image (B) of M. tuberculosis array possessing the tracking oligonucleotide. Open squares; denote 
elements where oligonucleotides were not deposited on slide surface. Open circles; denote elements where target-specific M. 
tuberculosis oligonucleotides were present in low concentration. Black arrowheads, negative controls containing tracking oligo-
nucleotide only.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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Quality control and data filtering using the tracking 
oligonucleotide
A major advantage to using a third-color tracking oligonu-
cleotide is the ability to efficiently monitor printing fidel-
ity on individual microarray slides in a given batch. To
monitor printing fidelity in our M. tuberculosis oligonucle-
otide set containing the 5'-fluoresceinated tracking oligo-
nucleotide, individual slides were analyzed for fluorescein
fluorescence before, or Cy5 and Cy3 fluorescence after
heterotypic hybridizations between wild-type M. tubercu-
losis H37Rv and the isogenic mprA mutant. Images from a
representative microarray are depicted in Figure 4. As
expected, rows containing negative controls consisting of
tracking oligonucleotide alone were visibly more fluores-
cent on the pre-hybridization fluorescein image relative to
spots containing tracking oligonucleotide co-spotted with
target specific oligonucleotide [Figure 4; panel A, black
arrowheads]. Interestingly, similar levels of fluorescein
fluorescence were also observed from a subset of printed
spots that contained both tracking- and target-specific oli-
gonucleotides [Figure 4; panel A, compare open circles
with black arrowheads]. This indicates that the concentra-
tion of target-specific oligonucleotide present in these
spots were at a lower concentration than expected, per-
haps due to synthesis failure. Consistent with this hypoth-
esis, little Cy5 or Cy3 fluorescence could be observed from
these spots following hybridization [Figure 4; panel B,
open circles]. Furthermore, fluorescein, Cy3, or Cy5 fluo-
rescence were not observed on pre-hybridization or post-
hybridization images for some spotted oligonucleotides
[Figure 4; panels A and B, open squares], suggesting that
probe DNA for these genes was not efficiently deposited
or immobilized on the glass surface. Thus, utilization of a
third-color tracking oligonucleotide is useful for quality
control measurements and differentiating false negatives
(synthesis failures and mechanical misses) from true neg-
atives (no gene expression).
This sets the stage for more sophisticated data filtering,
however, the signal intensity derived from the tracking
oligonucleotide will vary as a function of the binding
capacity of the slide, which is influenced by many varia-
bles including slide coating chemistry, slide coating lot,
printing conditions (temperature and humidity), as well
as post-processing variables. Therefore, the binding
capacity of the array must first be established using the
tracking oligonucleotide alone, to identify the maximum
fluorescein intensity for the slide. Quality slides with high
retention capacities will have high intensities, whereas
low quality/retention slides will not. Likewise, it is also
necessary to establish for each slide the fluorescein inten-
sity obtained when co-spotting 0.5 µM tracking oligonu-
cleotide with target-specific oligonucleotide at its proper
40 µM concentration, which is accomplished with a dilu-
tion series of positive controls, ie quantified, high synthe-
sis quality oligonucleotides, in known molar ratio with
tracking oligonucleotide printed on each array, such as
those in Figure 2. The thousands target-specific elements
of the array, which include a range of high to low synthe-
sis yield as well as mechanical misses, can now be gauged
against these positive and the negative controls.
We have previously shown for cDNA arrays that hybrid-
ized data quality is highly dependent on the amount of
immobilized probe [19], and this variable can be control-
led using directly labeled probe material and filtering
those spots that do not meet defined intensity thresholds.
Our current efforts include defining the lowest amount of
support-bound target oligonucleotide necessary to obtain
reliable ratio measurements, however there are a number
of issues to consider. First, cDNA probes typically average
about 1 kb in length, which is more than 10-fold the size
of a 70-mer oligonucleotide. Therefore it is reasonable to
assume that a given area of glass support will bind >10-
fold the number of copies of a 70-mer oligonucleotide
versus a 1 kb double-stranded PCR product and if ratio
data quality is dictated by the number of support-bound
copies of a probe sequence, it will be easier to achieve this
threshold with spotted oligonucleotides. The second con-
sideration is the signal dynamic range of the tracking oli-
gonucleotide and whether or not data impacting
differences in bound target-specific oligonucleotide (aside
from synthesis failures) can be measured with this
approach. We are currently investigating these issues with
the objective of defining the threshold of support-bound
probe necessary for reliable gene expression measure-
ments so that these compromising elements can be fil-
tered from data sets.
Variability of microarray data can arise from both biolog-
ical and technical sources. In this report, use of a fluores-
ceinated tracking oligonucleotide for quality control
purposes has been described. This three-color microarray
methodology can be utilized for pre-hybridization quality
assessment [18], to facilitate automated post-hybridiza-
tion image analysis [24], as well as post-hybridization
data filtering [19]. The ability to perform QC filtering on
printed slides allows identification of potentially prob-
lematic slides containing low amounts of probe available
for hybridization or high variation in spot morphology/
deposition across the array.
Methods
Mycobacterium tuberculosis 70-mer oligonucleotide set
The Operon (Alameda, CA) 4,269 Mycobacterium tubercu-
losis 70-mer oligonucleotide probe set was printed on in-
house poly-L-lysine coated slides prepared as previously
described [25]. Oligonucleotide probes present in this col-
lection were designed from the genomic sequence of M.
tuberculosis  strain H37Rv and M. tuberculosis strainBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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CDC1551, and include an additional 25 negative and 12
positive oligonucleotide controls. Lyophilized probes
were shipped in 384-well micro titer plates. Upon arrival,
probes were resuspended to a final concentration of 80
µM in deionized water and resuspended by incubation
overnight at 4°C with gentle shaking. Probes were diluted
2-fold into one of three 2 × printing buffers: 6x SSC (saline
sodium citrate), 100% DMSO (di methyl sulfoxide), or
30% DMSO containing 3.0 M betaine, thereby generating
oligonucleotide sets at a final concentration of 40 µM.
When required, a Staphylococcus aureus-specific 70-mer
"tracking" oligonucleotide synthesized with a 5'-fluores-
cein tag was added to the printing buffer at a final molar
ratio of 1:80 relative to the M. tuberculosis-specific
oligonucleotides.
Array Fabrication
Printing was performed with a GeneMachines Omni Grid
printer (San Carlos, CA) using Telechem International
SMP3 pins (Sunnyvale, CA) at 40% humidity and 22°C.
To control pin contact force and duration, the instrument
was set with the following Z motion parameters, velocity:
7 cm/sec, acceleration: 100 cm/sec2, deceleration: 100
cm/sec2. Following printing, oligonucleotides were UV
cross-linked to slides and processed using the previously
described nonaqueous blocking protocol [26]. Image files
on all arrays were collected before hybridization using
excitation and emission spectra specific for fluorescein
using a ScanArray 5000 (GSI Lumonics, Billerica, MA).
Generation of third-color Staphylococcus aureus-specific 
70-mer oligonucleotide and 5'-Cy5-labeled M. 
tuberculosis-specific 70-mer oligonucleotides
A 5'-fluoresceinated 70-mer oligonucleotide [5'-(FITC)-
ATGAAGAAACTATATACATCTTAT
GGCACTTATGGATTTTTACATCAGATAAAAATCAATAAC-
CCGACCC-3'] was generated to the S. aureus response
regulator trap and used as a third-color tracking oligonu-
cleotide in the M. tuberculosis 70-mer array. This gene has
been shown to be specific to S. aureus [27], and exhibits
no homology to any gene in the M. tuberculosis genome
(data not shown). For some experiments, two 5'-Cy5
labeled 70-mer oligonucleotides (Operon) were gener-
ated to the aceA  (Rv0467) [5'-Cy5-
GGATCAACAACGCACTGCAGCGCGCCGACCA-
GATCGCCAAGATCG AGGGCGATACTTCGGTGGA-
GAACTG-3'] and sodA  (Rv3846) [5'-Cy5-
CAAGCTGCTGAT
ATTCCAGGTTTACGACCACCAGACGAACTTC-
CCGCTAGGCATTGTTCCGCTGCTGCG-3'] genes of M.
tuberculosis  H37Rv. These genes are expressed during
growth of M. tuberculosis in laboratory medium in vitro
[28,29].
Growth of Mycobacterium tuberculosis H37Rv and 
preparation of DNA or RNA
M. tuberculosis H37Rv and the isogenic mprA mutant [30]
were grown at 37°C to an A600 ~ 1.2 in Middlebrook 7H9
broth (Difco, Sparks, MD) supplemented with 10% (vol/
vol) albumin-dextrose-catalase (Difco, Sparks, MD) and
0.05% (vol/vol) Tween 80 (Sigma, St. Louis, MO). DNA
was prepared from M. tuberculosis as previously described
[31]. For preparation of RNA, bacterial cells from a 50.0
ml culture were transferred to a conical tube and concen-
trated by centrifugation. Cells were resuspended in Tel-
Test RNA-Bee (Friendswood, TX) and mechanically lysed
using a bead beater (BioSpec Products, Bartlesville, OK) as
described [32]. Total RNA was chloroform extracted and
precipitated by the addition of isopropanol. The resulting
RNA pellet was resuspended in DEPC-treated water and
treated with DNase I (Ambion Inc., Austin, TX) to remove
contaminating DNA, and re-purified by affinity chroma-
tography using RNeasy purification columns (Qiagen,
Valencia, CA). To reduce ribosomal RNA content, 10 µg of
DNAse I-treated total RNA was enriched for mRNA using
the MICROBExpress™ bacterial mRNA purification kit
(Ambion).
Labeling and hybridization of M. tuberculosis RNA or DNA
Enriched mRNA or PCR-amplified DNA was used as tem-
plates for labeling reactions microarray hybridization
experiments. Test hybridizations utilized aceA (Rv0467)
and sodA (Rv3846) Cy 3-labeld PCR products amplified
from genomic M. tuberculosis H37Rv DNA using primers
[aceAF (5'-GATCCAGCAGGAATGGGACAC-3') and
aceAR (5'-CAGACTAGTGGAACTGGCCCTCT-3')] and
primers [sodAF (5'-GCCAGACCTGGACTGGGACTA-3')
and sodAR (5'-CCGAATATCAACCCCTTGGTCT-3')]. For
heterotypic hybridizations, labeled cDNAs were synthe-
sized using SuperScript™ III Reverse Transcriptase (Invit-
rogen, Carlsbad, CA), a cocktail of synthetically generated
decamers [33], and Cy3- or Cy5-dCTP (Amersham, Piscat-
away, NJ). Cy3- and Cy5-labeled templates were purified
using a Qiagen MinElute kit, and concentrated using Ami-
con YM 30 columns. The concentrated mixed probes were
added to a solution containing 50% formamide, 0.1%
SDS, and 5X SSC. Hybridization of M. tuberculosis array
slides were performed in sealed humid hybridization cas-
settes for 16–20 h at 42°C. All slides were pre-hybridized
with 0.1% BSA solution in 5X SSC and 0.1% SDS for 30
min at 42°C. Following hybridization, array slides were
washed at room temperature for 1 minute each in 2X SSC/
0.1% SDS, 1X SSC, 0.2X SSC, and 0.05X SSC and then
dried by centrifugation. Following hybridization
reactions, arrays were scanned using excitation and emis-
sion spectra specific for Cy3 and Cy5. Scanning was per-
formed using a ScanArray 5000 (GSI Lumonics, Billerica,
MA).BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/12
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Data analyses and statistics
Microarray images were processed with Matarray, which
has been extended to process three images simultane-
ously, in particular utilizing the advantages of the pre-
hybridization FITC image to assist signal segmentation
and quantification [20,24]. Data filtering and normaliza-
tion were performed utilizing the quality score qcom
defined in Matarray [21]. Statistical analysis was per-
formed in Matlab using its statistical toolbox and mod-
ules developed in house.
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